JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.51B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$818M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$596M |
| 4 |
Eaton
ETN
|
+$577M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$557M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$727M |
| 3 |
Starbucks
SBUX
|
+$679M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$565M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$458M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.34% |
| 2 | Technology | 11.83% |
| 3 | Healthcare | 9.48% |
| 4 | Consumer Discretionary | 7.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLRN
2726
DELISTED
Acceleron Pharma
XLRN
| $3.29M | ﹤0.01% |
+91,900
| New | +$3.19M |
|
|
ESL
2727
DELISTED
Esterline Technologies
ESL
| $3.29M | ﹤0.01% |
36,043
+15,424
| +75% | +$1.39M |
|
2728
National CineMedia
NCMI
$252M
| $3.29M | ﹤0.01% |
46,600
+40,570
| +673% | +$2.62M |
|
|
XIFR
2729
XPLR Infrastructure LP
XIFR
$1.09B
| $3.28M | ﹤0.01% |
81,762
-38,762
| -32% | -$1.54M |
|
2730
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12B
| $3.27M | ﹤0.01% |
28,679
+9,654
| +51% | +$1.08M |
|
|
MLPI
2731
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
| $3.27M | ﹤0.01% |
130,691
+12,797
| +11% | +$325K |
|
2732
Alarm.com
ALRM
$2.74B
| $3.27M | ﹤0.01% |
+72,570
| New | +$3M |
|
2733
Travere Therapeutics
TVTX
$5.79B
| $3.27M | ﹤0.01% |
132,132
-5,394
| -4% | -$119K |
|
2734
Rigel Pharmaceuticals
RIGL
$762M
| $3.25M | ﹤0.01% |
139,865
-6,290
| -4% | -$153K |
|
2735
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.4B
| $3.24M | ﹤0.01% |
109,327
-120,519
| -52% | -$3.57M |
|
|
ZGNX
2736
DELISTED
Zogenix, Inc.
ZGNX
| $3.24M | ﹤0.01% |
251,600
-34,699
| -12% | -$471K |
|
2737
HNI Corp
HNI
$3.56B
| $3.24M | ﹤0.01% |
78,228
+28,448
| +57% | +$1.07M |
|
2738
CALL
Occidental Petroleum
OXY
$57.7B
| $3.24M | ﹤0.01% |
49,800
+17,800
| +56% | +$1.08M |
|
2739
CALL
Sarepta Therapeutics
SRPT
$1.95B
| $3.23M | ﹤0.01% |
+68,500
| New | +$2.74M |
|
|
AET
2740
PUT
DELISTED
Aetna Inc
AET
| $3.23M | ﹤0.01% |
20,500
-6,000
| -23% | -$937K |
|
|
NEFF
2741
DELISTED
Neff Corporation
NEFF
| $3.23M | ﹤0.01% |
129,003
+48,128
| +60% | +$1.1M |
|
2742
Vanguard Total World Stock ETF
VT
$81.9B
| $3.22M | ﹤0.01% |
45,795
-65
| -0.1% | -$4.51K |
|
|
PRTY
2743
DELISTED
Party City Holdco Inc.
PRTY
| $3.21M | ﹤0.01% |
231,939
+119,806
| +107% | +$1.71M |
|
2744
LGI Homes
LGIH
$1.37B
| $3.2M | ﹤0.01% |
66,907
+39,943
| +148% | +$1.78M |
|
|
TLP
2745
DELISTED
Transmontaigne
TLP
| $3.2M | ﹤0.01% |
74,658
+68,960
| +1,210% | +$3.03M |
|
2746
Navios Maritime Partners
NMM
$2.31B
| $3.18M | ﹤0.01% |
101,076
+15,132
| +18% | +$429K |
|
2747
CALL
F5
FFIV
$23.6B
| $3.16M | ﹤0.01% |
+26,000
| New | +$3.14M |
|
2748
Herc Holdings
HRI
$5.64B
| $3.15M | ﹤0.01% |
65,195
-64,246
| -50% | -$2.79M |
|
|
LBY
2749
DELISTED
Libbey, Inc.
LBY
| $3.15M | ﹤0.01% |
333,038
+8,938
| +3% | +$73.2K |
|
|
VEDL
2750
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $3.15M | ﹤0.01% |
164,332
+89,368
| +119% | +$1.65M |
|
Similar funds
JP Morgan Chase's Q3 2017 Portfolio in Review
As of Q3 2017, JP Morgan Chase held 5,458 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2017 filing shows 502 new, 2,053 increased, 1,909 reduced and 470 closed positions. Its largest new stake was JBG SMITH: 3,403,127 shares worth $116M. The largest sale was Du Pont De Nemours E I, an estimated $1.4B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2017 buy was JBG SMITH: 3,403,127 shares worth $116M.
- JP Morgan Chase added most to DuPont de Nemours in Q3 2017, an estimated $1.51B increase.
- JP Morgan Chase's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $727M.
- JP Morgan Chase fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.4B.
- JP Morgan Chase's ten largest holdings make up 18% of its $453B portfolio in Q3 2017.
- JP Morgan Chase opened 502 new positions and closed 470 in Q3 2017.
- JP Morgan Chase's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on JP Morgan Chase's 13F filing for Q3 2017, filed 9 Nov 2017.